# SATB2

## Overview
SATB2 is a gene that encodes the SATB homeobox 2 protein, a transcription factor involved in chromatin organization and gene regulation. The SATB2 protein is characterized by its DNA-binding motifs, including two CUT domains and a homeodomain, which facilitate its role in transcriptional regulation and chromatin remodeling (Zarate2019Mutation; Dobreva2003SUMO). As a nuclear matrix protein, SATB2 binds to AT-rich sequences in nuclear matrix-attachment regions, influencing chromatin structure and gene expression (Zhao2014The). It plays a significant role in various biological processes, such as skeletogenesis, craniofacial development, and neuronal differentiation, and is crucial for cognitive functions, synaptic plasticity, and long-term memory (Zhao2014The; Cera2019Genes). Mutations in the SATB2 gene are linked to SATB2-associated syndrome, characterized by intellectual disability, speech delay, and craniofacial abnormalities, underscoring its clinical significance (Zarate2018Natural; Copelli2023SATB2Associated).

## Structure
The SATB2 protein is a 733-amino-acid protein with a molecular weight of approximately 82.6 kDa (Zarate2019Mutation). It contains two CUT domains and a homeodomain, which are highly conserved across vertebrate taxa and serve as DNA-binding motifs (Zarate2019Mutation). The CUT domains, specifically CUT1 and CUT2, are involved in chromatin interaction, with CUT1 initiating interaction and CUT2 facilitating dissociation from chromatin (Zarate2019Mutation). The homeodomain is crucial for DNA binding and is a common feature in proteins involved in transcriptional regulation (Dobreva2003SUMO).

SATB2 is subject to post-translational modifications, including SUMO conjugation at lysine residues K233 and K350, which are critical for its modification and influence its subnuclear localization and gene activation potential (Dobreva2003SUMO). These modifications can alter SATB2's interactions, localization, and stability (Dobreva2003SUMO).

The protein is capable of forming higher-order structures through interactions with other proteins, such as its homolog SATB1, mediated by their PDZ domains, which are essential for its transcriptional activity and chromatin organization (Zhou2012The). The presence of different isoforms due to alternative splicing is suggested, although specific details are not provided in the context.

## Function
The SATB2 gene encodes a nuclear matrix protein that plays a crucial role in transcription regulation and chromatin remodeling. It binds to AT-rich sequences in nuclear matrix-attachment regions (MARs), influencing chromatin structure and gene expression (Leoyklang2013Disorders; Zhao2014The). SATB2 is involved in various biological processes, including skeletogenesis, craniofacial development, and neuronal differentiation. It acts as a transcription factor, interacting with other transcription factors like Runx2 and ATF4 to regulate osteoblast differentiation and bone formation (Döcker2013Further; Zhao2014The).

In the central nervous system, SATB2 is expressed in pyramidal neurons across all cortical layers and is a key regulator of synaptic plasticity and long-term memory. It is associated with cognitive functions, with common variations linked to schizophrenia risk and rare variants leading to intellectual disabilities (Cera2019Genes). SATB2's role in cognitive abilities is supported by its interaction with proteins involved in synaptic transmission and plasticity, processes underlying cognitive functions (Cera2019Genes).

SATB2 also regulates the expression of the UPF3B gene, which is part of the nonsense-mediated mRNA decay complex, highlighting its role in maintaining normal cellular function (Leoyklang2013Disorders).

## Clinical Significance
Mutations in the SATB2 gene are associated with SATB2-associated syndrome (SAS), a multisystem disorder characterized by intellectual disability, severe speech delay, craniofacial abnormalities, and behavioral problems. This syndrome is often caused by de novo mutations, including large deletions, small intragenic deletions, and microduplications, which lead to haploinsufficiency of the SATB2 gene (Zarate2018Natural; Copelli2023SATB2Associated). 

Clinical manifestations of SAS include delayed intellectual and language development, dental anomalies, and craniofacial malformations such as cleft palate and micrognathia (Thomason2019Speech; Liu2023Genetic). The gene's role in neuronal projection development and osteoblast differentiation contributes to these phenotypes (Döcker2013Further). 

Alterations in SATB2 expression are also linked to other conditions, such as osteoporosis and craniosynostosis, due to its involvement in bone homeostasis and craniofacial patterning (Zhao2014The). SATB2 mutations can lead to increased apoptosis in craniofacial mesenchyme, affecting the expression of genes critical for craniofacial development (Zhao2014The). The gene's disruption is implicated in Toriello-Carey syndrome and other syndromic cognitive impairment disorders, highlighting its broad clinical significance (Leoyklang2013Disorders; Zhao2014The).

## Interactions
SATB2 is a transcription factor that interacts with various proteins and nucleic acids, playing a significant role in chromatin organization and gene regulation. It binds to matrix attachment regions (MARs) of DNA, facilitating the transcription of specific genes such as the γ-globin genes by recruiting histone acetylase PCAF, which enhances promoter activity (Zhou2012The). SATB2 also interacts with SATB1, another MAR-binding protein, to regulate gene expression and organize higher-order chromatin structures (Zhou2012The).

In embryonic stem cells, SATB2 undergoes SUMOylation mediated by the E3 ligase ZFP451, which is crucial for the transition from pluripotency to differentiation. This modification allows SATB2 to interact with the LSD1/CoREST complex, downregulating pluripotency genes and promoting differentiation (Antonio2021ZFP451mediated). PIAS1, another SUMO E3 ligase, also enhances the sumoylation of SATB2, specifically at lysines K233 and K350, further modulating its activity (Dobreva2003SUMO).

In the cerebral cortex, SATB2 interacts with various proteins, including HDAC1, and is involved in synaptic plasticity and long-term memory. Its interactome includes proteins associated with chromatin architecture, such as the NuRD complex and nuclear lamina-associated proteins, which contribute to cognitive function (Cera2019Genes).


## References


[1. (Thomason2019Speech) Ashlen Thomason, Emily Pankey, Beth Nutt, Aisling R. Caffrey, and Yuri A. Zarate. Speech, language, and feeding phenotypes of satb2‐associated syndrome. Clinical Genetics, 96(6):485–492, August 2019. URL: http://dx.doi.org/10.1111/cge.13619, doi:10.1111/cge.13619. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cge.13619)

[2. (Liu2023Genetic) Qian Liu, Nan-Nan Feng, and Lin-Jiao Chen. Genetic analysis of a child with satb2‑associated syndrome and literature study. Experimental and Therapeutic Medicine, June 2023. URL: http://dx.doi.org/10.3892/etm.2023.12071, doi:10.3892/etm.2023.12071. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/etm.2023.12071)

[3. (Copelli2023SATB2Associated) Matheus de Mello Copelli, Eleonore Pairet, Milena Atique-Tacla, Társis Paiva Vieira, Simone Appenzeller, Raphaël Helaers, Miikka Vikkula, and Vera Lúcia Gil-da-Silva-Lopes. Satb2-associated syndrome due to a c.715c&gt;t:p(arg239*) variant in adulthood: natural history and literature review. Genes, 14(4):882, April 2023. URL: http://dx.doi.org/10.3390/genes14040882, doi:10.3390/genes14040882. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes14040882)

[4. (Zhou2012The) Li-Quan Zhou, Jie Wu, Wen-Tian Wang, Wei Yu, Guang-Nian Zhao, Peng Zhang, Jian Xiong, Man Li, Zheng Xue, Xing Wang, Xue-Min Xie, Zhi-Chen Guo, Xiang Lv, and De-Pei Liu. The at-rich dna-binding protein satb2 promotes expression and physical association of human γ- and γ-globin genes. Journal of Biological Chemistry, 287(36):30641–30652, August 2012. URL: http://dx.doi.org/10.1074/jbc.m112.355271, doi:10.1074/jbc.m112.355271. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m112.355271)

[5. (Cera2019Genes) Isabella Cera, Laura Whitton, Gary Donohoe, Derek W. Morris, Georg Dechant, and Galina Apostolova. Genes encoding satb2-interacting proteins in adult cerebral cortex contribute to human cognitive ability. PLOS Genetics, 15(2):e1007890, February 2019. URL: http://dx.doi.org/10.1371/journal.pgen.1007890, doi:10.1371/journal.pgen.1007890. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1007890)

[6. (Zarate2018Natural) Yuri A. Zarate, Constance L. Smith‐Hicks, Carol Greene, Mary‐Alice Abbott, Victoria M. Siu, Amy R. U. L. Calhoun, Arti Pandya, Chumei Li, Elizabeth A. Sellars, Julie Kaylor, Katherine Bosanko, Louisa Kalsner, Alice Basinger, Anne M. Slavotinek, Hazel Perry, Margarita Saenz, Marta Szybowska, Louise C. Wilson, Ajith Kumar, Caroline Brain, Meena Balasubramanian, Holly Dubbs, Xilma R. Ortiz‐Gonzalez, Elaine Zackai, Quinn Stein, Cynthia M. Powell, Samantha Schrier Vergano, Allison Britt, Angela Sun, Wendy Smith, E. Martina Bebin, Jonathan Picker, Amelia Kirby, Hailey Pinz, Hannah Bombei, Sonal Mahida, Julie S. Cohen, Ali Fatemi, Hilary J. Vernon, Rebecca McClellan, Leah R. Fleming, Brittney Knyszek, Michelle Steinraths, Cruz Velasco Gonzalez, Anita E. Beck, Katie L. Golden‐Grant, Alena Egense, Aditi Parikh, Chantalle Raimondi, Brad Angle, William Allen, Suzanna Schott, Adi Algrabli, Nathaniel H. Robin, Joseph W. Ray, David B. Everman, Michael J. Gambello, and Wendy K. Chung. Natural history and genotype‐phenotype correlations in 72 individuals with satb2‐associated syndrome. American Journal of Medical Genetics Part A, 176(4):925–935, February 2018. URL: http://dx.doi.org/10.1002/ajmg.a.38630, doi:10.1002/ajmg.a.38630. This article has 56 citations.](https://doi.org/10.1002/ajmg.a.38630)

[7. (Leoyklang2013Disorders) Petcharat Leoyklang, Kanya Suphapeetiporn, Chalurmpon Srichomthong, Siraprapa Tongkobpetch, Stefanie Fietze, Heidi Dorward, Andrew R. Cullinane, William A. Gahl, Marjan Huizing, and Vorasuk Shotelersuk. Disorders with similar clinical phenotypes reveal underlying genetic interaction: satb2 acts as an activator of the upf3b gene. Human Genetics, 132(12):1383–1393, August 2013. URL: http://dx.doi.org/10.1007/s00439-013-1345-9, doi:10.1007/s00439-013-1345-9. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-013-1345-9)

[8. (Zarate2019Mutation) Yuri A. Zarate, Katherine A. Bosanko, Aislling R. Caffrey, Jonathan A. Bernstein, Donna M. Martin, Marc S. Williams, Elizabeth M. Berry‐Kravis, Paul R. Mark, Melanie A. Manning, Vikas Bhambhani, Marcelo Vargas, Andrea H. Seeley, Juvianee I. Estrada‐Veras, Marieke F. Dooren, Maria Schwab, Adeline Vanderver, Daniela Melis, Adnan Alsadah, Laurie Sadler, Hilde Esch, Bert Callewaert, Ann Oostra, Jane Maclean, Maria Lisa Dentici, Valeria Orlando, Mark Lipson, Steven P. Sparagana, Timothy J. Maarup, Suzanne IM Alsters, Ariel Brautbar, Eliana Kovitch Thropp, Sakkubai Naidu, Melissa Lees, Douglas M. Smith, Lesley Turner, Víctor Raggio, Lucía Spangenberg, Sixto Garcia‐Miñaúr, Elizabeth R. Roeder, Rebecca O. Littlejohn, Dorothy Grange, Jean Pfotenhauer, Marilyn C. Jones, Meena Balasubramanian, Antonio Martinez‐Monseny, Lot Snijders Blok, Ralitza Gavrilova, and Jennifer L. Fish. Mutation update for the satb2 gene. Human Mutation, April 2019. URL: http://dx.doi.org/10.1002/humu.23771, doi:10.1002/humu.23771. This article has 24 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.23771)

[9. (Zhao2014The) Xiaoying Zhao, Zhihu Qu, Jennifer Tickner, Jiake Xu, Kerong Dai, and Xiaoling Zhang. The role of satb2 in skeletogenesis and human disease. Cytokine &amp; Growth Factor Reviews, 25(1):35–44, February 2014. URL: http://dx.doi.org/10.1016/j.cytogfr.2013.12.010, doi:10.1016/j.cytogfr.2013.12.010. This article has 57 citations.](https://doi.org/10.1016/j.cytogfr.2013.12.010)

[10. (Antonio2021ZFP451mediated) Gustavo Antonio Urrutia, Haribaskar Ramachandran, Pierre Cauchy, Kyungjin Boo, Senthilkumar Ramamoorthy, Soeren Boller, Esen Dogan, Thomas Clapes, Eirini Trompouki, Maria-Elena Torres-Padilla, Jorma J. Palvimo, Andrea Pichler, and Rudolf Grosschedl. Zfp451-mediated sumoylation of satb2 drives embryonic stem cell differentiation. Genes &amp; Development, 35(15–16):1142–1160, July 2021. URL: http://dx.doi.org/10.1101/gad.345843.120, doi:10.1101/gad.345843.120. This article has 12 citations.](https://doi.org/10.1101/gad.345843.120)

[11. (Döcker2013Further) Dennis Döcker, Max Schubach, Moritz Menzel, Marita Munz, Christiane Spaich, Saskia Biskup, and Deborah Bartholdi. Further delineation of the satb2 phenotype. European Journal of Human Genetics, 22(8):1034–1039, December 2013. URL: http://dx.doi.org/10.1038/ejhg.2013.280, doi:10.1038/ejhg.2013.280. This article has 72 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2013.280)

[12. (Dobreva2003SUMO) Gergana Dobreva, Julia Dambacher, and Rudolf Grosschedl. Sumo modification of a novel mar-binding protein, satb2, modulates immunoglobulin μ gene expression. Genes &amp; Development, 17(24):3048–3061, December 2003. URL: http://dx.doi.org/10.1101/gad.1153003, doi:10.1101/gad.1153003. This article has 215 citations.](https://doi.org/10.1101/gad.1153003)